Do¢￿1￿n En¥*k)pe ID.. 67DoF45Lk315&4EBW2&1f￿D￿fi75Fo Charity Regl¥tratlon No. 1182637 (England *nd Wakjl Ch•rfty Reglstratlon No. SC049948 Iscothndl Company R•glitratlon No. CE0169S1 (England and Waknil THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 DoytsKJn En¥eW ID.. 67DOF45fh315&4EW02>1D60D72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION LEGAL AND ADMINISTRATIVE INFORMATION Tw$t Oavwj Oxnam (Chair of Board of Trustees) Rachel Wlojx S8rah Curb"8 DrAngeÉa Polanco (Appointed 13 June 20251 Chl•f ExKull Ashley Bamamble Charlty numb•r 1182637 (England and Wale$} SC049948 IScA)Ilandl Company numb•r CE016951 Op•r•tlng o)•m• CCLG Princlpal •ddr••• Ctnlury House 24 D8 Monrfort Street Leicesler LEI 7G8 Audltor N￿bY Caslleman LLP st Walk Building 110 Regent Road L*i¢oster LE1 7LT Bankern HSBC Bank PIC 24 Galltywtree Gale L•icester LE1 1DA Sc¢ltish Wbjows Bank Pk PO Box 12757 87 Mo￿lSOn Street Edinburgh EH3 8YJ CAF 8ank Ltd 25 ￿"n9$A¥*Th Kings HIII Kenl ME19 4JQ Dorthlgn Enweknpe ID". 67DCf45tk315$4EBW2&1C*DD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION CONTENTS Pa Tnjstees. report Indo￿ndent audrtorfs rewl 13-15 Stslemenl ol financial ￿tly￿￿$ 16 Balance sheet 17 Slalement of cash Ihjws 18 Notes lo the fin8ncial ststement8 19-33 Docusvjn En¥￿0￿ ID.. 67DOF45N15>*BW2>1CrfDDn675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 The trustees of The Children's Cancer and Leukaemra Group, trading as CCLG.. The Children & Young People's Cancer Association ICCLGI. are P￿sed lo present their annual report and financial statements for the year ended 310ecerrthr 2024. The financial statements have been prepared in accordance wrth the accounting policies set out in the notes lo the accounts and wmpty with the charity's governing d(xumenl, the Financial Reporting Standard applicablg in tho Unilod Kingdom and Republic of IreL8nd I"FRS 102.1, Aceounlin9 and Reporting by Charrties.. th& Ststemenl of Recommended Practice for chanties applying FRS 102120191. the Charities Act 2011, the Charrties and Trustee Investment Iswllandl Act 2005. and UK Generally Accepted Accounts'ng Practice. EC The obj'ectives of CCLG as deffined in t￿ Constitution are.. For th¢ puts1￿ benefil, the relief of S￿ne$S and suffenng of chikjren, teenagèrs and young aduts with cancgr and advancement ol educat￿n in the fiekl of chikjren. leenthyrs and young adutts with cancer. in particular but not exclusivety by.. 1. The reliefof sKkness and promotion and protection ol goc4J health by supporting research into the nature. CaU88s, diagnosis, I￿*1Ment and social consequences of cancer in children. teenagèfs and young adults. and lo publish the useful re$utts of such research. 2. The rel￿ ol suffering of chihjren. leenagers and youn9 adutts with eancer and their families and carers, through the provis￿￿ ol infomation and support servus to them. 3. The advancement ol the educatKJn of the publ￿ in all areas r810ts.ng to cancer in children, teenagers and young aduhs. 4. Thè advancémént ol edUcat￿n and clinKal prx1l￿ by the dissemination of kn¢)wledge of the latèst research and best proclice anv)ngst professionals and practrtioners engaged in the treatment, carg and support of chitdren, teenagers and young adutts wrth cancer. The main ben8fKiar*s ol the work carTted out by the charity aro children. teenager8 and young adutt8 with cancer and their familiès in the Unrtgd Kingdom and elsewhere in the world. CCLG 18 the UK and Ireland's professh)nal ￿5￿lati¢)n for all Ihose involved in the treatment, care and research of children and young people laged 0-251 with cancer. At the end of 2024. our membership had grown lo more than 1.800 members. We also operate 'Teenagers and Young Adults with Cancer. ITYACI, a specific membership group for those working wrth young peop￿ aged 13-2S wrth a cancer diagnosis, which had over 470 members al tho end of the year. We bring together the èxperts in chiklren and young people's cancer thmugh our profe$sKJnal membership, creating a powerful national nets￿rk driving progress. Tcgelher. we shape better Irealmgnt and care developing guidelines, sharing expertise. offering advKe, leading groundbreaking research, and creating essential resoyr¢es and education for profes$K)nals. Our cdknlive experts.se Sets the standard, a(fvi$ing, influencing, and advocating for excel￿nCe locally. nalionalty, and globalty- We carry out a wKle range of aclNrties lo support our profes$K)nal members. including." Sp￿la1 Interesi Groups and Member Networks". Our Special Interest Groups ISIGS) bring together nthorks of mgmbers around specrfK cancer type5, profesS￿nS or discipline$, and key aspects of Irealment and care. Our SIGS develop treatment gU￿elIneS, produce good practice guidance and resources to help professionals develop in their careers. develop and run educatKJnal opportunrties for professp)nals, creale nthv research projects. undertake qualty improvement inrtiatives, prowde ne￿orkS for sharing best praCt￿e and new idea$. and lois more. with the uliim*e aim of ensuring the best possible treatment and care for all children and young peop￿. Cllnlcal treatment guidelines". We develop national clinical treatment gufvjelines ensuring safe, consistent and sl8ndardised Care for children with cancer. Where possible, children with cancer ar8 Dovjsign Envew ID." 67D(F45D415>lEB￿&f(￿D72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Irealed on clini￿1 trials. However, the nature of research means that there will not aKvays be open trials for SO￿ childhood cancers and using Ireatrr*nt guhlelines Is vital for ensuring equality of access lo wh81 is ￿arded by nalK*nal experts as the best possib￿ treatment currently available. CCLG members regularty re¥￿W guhlance and recommendations to Cover 811 of the major ¢hiklren's eancers, including leukaemia. Our guidelines are written by national experts in the field of each lumur type, usually by members of the relevant CCLG Special Interest Group. GU￿anCe and wommendations draw on ov#Jence from inleination81 research and treatment protocols. and the aim is to ensure 9uidance is consislenl with the standard of care internationalty. Educatlon and professlonal development". CCLG dèveknps exwt resources lo support children and young poople's cancer professN)nals in their careers. as well as providing professional education through meetings. conferences and webinars. We support the next generation of profeSs￿nal$ including through our Paedialric Oneobgy Trainees Group and Eaty Career Researcher Nefv40rk. Our member w•bsit•' is a vrtal hub for profeSS￿nal5. prov￿Ing a wearth of resources and educational opportunities, ¢omplemenled by our online member eommunity, allowing networking and g¢)od practice sharing opportunil*s beyond group meetings and everits. Proftrs8lonal volc• for ch51dr•n. to•nag•rn and young adults". We advise governments and other bodies and ensure Ihal we are represenled on important groups or in consuttalions. for example in the area of NHS commisS￿ning of children's cancer se￿￿$ or the dgvebpment of NICE quality standards and guidance. Our member8 are dedicated lo &n$uring that chiklren and young people have a greater chance of Survival and a better lrfe after Irealmenl. mialion and uidance We 8UPPOrt children and young Peop￿ with cancer and Iheir families in a variety of dtfferent ways.. We provide Irusled infomalion and guidance for children ond young people with cancer, their familk*S, and everyone supporting them. Our expertise helps them navigole the challen9è5 of cancer and rts impact, offering reassurance and clarty whon it's needed mosl. OUT frae booklets and factsheets. ak)ng wrth v￿805 and our websrte, are a comprehensive resource for children and young people fxing cancer, along with their families. Wrrtten by experts, including Ihos8 with INed experience of chik1￿n and young people's Can￿r. our information 1$ reviewed reguiarly and accredited lo the PIF Tick certrfUt￿n, So users can be assured il is trustworthy, and produced using strict quality crileria. Our free quartety magazine. Contact, offern help, support and inforrnat￿n lor famil￿9 of children, teenagers and young adults with cancer. Our online communrty provides a 'safe $p8co' for parents of children with can￿r to come together and Share experiences, ask for advu, and, uniquely. ask expert questions of our professional membership. Our websrte is a comprghensNe resource of ehilahood cancer informat￿n, provKling a wide range of up- ttsdate expert information, personal stories and mre. The inC￿dIble pro9￿$$ in I￿atIng cancer in chik1￿￿ and young people is buitt on decades of dedicated research and elinical trials. Over the last 40 years. Ihis research has transformed survival rates, with more than 80Yo of children now being cured. CCLG has been at the heart of this progress. driving research and ollaborolion lo improve outcoffes. Bul there is still more to do. Some cancers remain d[ir￿ull lo treat. and many existing treatments cause long- lem and lrfxhangiThJ SKle effects. We need more research lo improve survival rates. develop kindor Irealmenls, and ensure the best possible qualty of lrfe foi childffjn and young people after cancer. At CCLG, we fund and support research across the entire can￿r pathvffjy-from d￿gnoSiS and treatment lo patient experience and survivorship. We make sure research meets the ￿al needs of Children and young people with cancer, their faMil￿s, and those who care lor them. In 2022. we Klentrfied the top 10 priorf(ies for chilJhLX)d cancer research. Shaped by the voKes of chldren. young people, parents, and professionals. Docu8yn En¥eloFe10'. 67D0F45f￿3lWEBw2&l[*DD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG. THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT ICONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Cdlaboralion is at the heart of wh* we do. We work with leading researehers and organisations to drive forward impactful $ludie$. on$uring the best projects and brightest minds receive funding. We partner wrth other charities lo maximise investment in research and use our expertise to support smaller charIt￿S in funding high-quality slvdies wrth real Impact. We lead the UK Children'$ and Teenage. Young Aduft & Gemi Cell Tumour Cancer Clinical Research Groups, shaping and overseeing clinul research across the UK. OUT Special Interest Groups bring together experts lo share knowledge and pkn firture re6eaTeh. We ¢Teale opportunit￿S for discovery. We organise and support s¢*nI[f￿ meetings. ensuring vital research 1$ shared, discussed, and developed. We empower our profeSs￿n81 mèmbership to be activety involved in shaping research. Our Earty Camr Research Netsyork and dedicated funding for nurses, allied he8kh prOfess￿n31$, and eady1EfjDD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG. THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES, REPORT ICONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 We raise awareness of the syn$ and symptoms. eMp￿￿ering faMil￿S and communities lo act sooner. For heatthcare professionals, we pro￿de l¢x)Is and resources lo support infomed decisions aboirt lesls and scans. Togfjther, we're wothing to ensure every child and young person get5 the timety diagnosis they need. Vve have information about the signs and symptoms of cancer in children and young people, and infomialion and resources for healthcare profe￿lOnaL$ about diagnosing cancer in chiklren and young people. During the year we continued lo focus on research to generate a new evidence base on how cancer presents in children and young people, as well as the routes lo diagnosis. lo infomi a new national ￿mPaign. Child Cancer Smart, which will launch in 2025. Chikj Cancer Smart will raise awareness of the Signs and symptom5 of children's cancer, and provide tooLs for GPS and other healthcare profèssional$ lo support them to make timely and a￿Urate ieferrals. We measu18 our success in ach￿VIng our objedr¥e5 in a of ways.. Anatytics around our heatth infofmalion provis￿n. including the number of infomialion products dislributfjd, website and S￿la1 media anamics. and USèT*rov*Jad feedbxk. are used lo maasure our work in supporting patients and their famil*s. The number of members and relenlKJn of mombers. attendance at and written feedback ffom education days. meetings and wnleren¢e¥. and infomw rr*mber feedback, are some basic measures used lo ascertain how we are supporting the cLynmunty of professionals we serve through our professional association activr¢ies. The number of research projects furKled and their ¥3￿8, and the OLrtcome of research projects including peer-reviewed papèrs in sc*ntffj￿ journa￿. and the nunknr of proj'ects that led lo further funding from ourselves or another research fvn¢Jer. We have now begun developing our new strategic P￿n, set lo 13unch in 2026. As part of this work, we will Consider how we better me8$ure and rnport on our Inpact. ACH EVEMENTS AND PERFORMANCE Around 1,800 ¢hiklren lagod 0-141 and a further2.300 teenagers and young adums laged 15-251 are diagnosed with cancer each year in the UK. Ahhough overall five•year SUTvwal for ￿nCer in children and young people is nowover 800A, for some eaneers there have not been such dramat￿ imprOve￿￿nIS in 5urwval, and even where Irealmenl 1$ successful, many survivofs have to contend wrth lrfe-long and lrfe-limrting side effects. We continue lo work towards the four main goals set out in our strategic pLqn, launched in 2018, and the goals of the TYAC strategi¢ plan, launched in 2019. as detailed bekx. High1￿hts of our aehieverr*nls during the year are sel out undgr each of these strategic goals. Providin feadershi and ex for the Ireal nt and ￿re of chI￿ren and oun le with ￿nCer As the UK and Ireland's pr¢)fessh)nal a$s￿laI￿an for those working in thè fiekl of paed￿triC oncology and haemalology, CCLG is a leading voKe for chiklren's caneer, liaising wrth communily groups, thè government and the NHS to inf uence pOI￿leS. We use our expertise to improve treatment and care and moel the needs of palienls and families. Highlwh15 for 2024 include.. OurAnnual Conference ¢onlinue$ to be the key proleSsN￿8l event in children's. l¢enage and young adutt cancèr. This year we welcomed a record 600+ delegates to our two-day event. providing a unique gpportunty for Th￿l¢al. heahhcare and research professionals lo come 109olher and share news and diKoveries. The conlerence featured our second annual Mambor Excellence Awards ceremony, celebraling the outstsnding contribution of members lo the work of CCLG and Child￿n and young people with cancer. The conference also sh¢7wcased Tesearch. wardin9 PreSt￿louS CCLG Research Awards in a variety of alegories re¢ognising wodil4EBWJ1￿DD72675Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT ICONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 We continued to Produce and update a number of clinKal Irealment guidelines. ensuring slandardised, high qvalty and evidence-based t￿atment for all Children. part￿ulaty in diseases where the￿ is eurrenlly no open clin￿al trial Our online mernber communty. CCLG Conned, continued lo go from strength to Strèngth, providing a space for members lo connect with each other. participate in group aclivrtiès, share besl•ractice and research outputs. ask questions and disseminate useful resources. Our strategic partnership with Young Lives vs Cancer continued. W0v￿1ng ber+efits to both organisations. The Ch￿f Nurse role at CCLG is funded by Young LNes vs Cancer, wothing to provKle clinical and heatth system in$NJhl and intelligence lo the lattef and enhance support for nursing and aLl￿d heaKh professional$ within CCLG. In 2022, in partnership with Youn9 LNes vs Cancer, the Ellen Ma&4rthur Cancer Trust, and Teenage Cancer Trust. we commissioned a ground-breaking piece of research that will build a new evidence base k)oking al the psychosocial neod$ of young cancer Pat￿nts and the current system supports them. Dartinglon serV￿e DeS￿n Lab. a charity whKh improves chiklren's outcomes through research, system5 thinking and co-design approaches, was commissioned as the research partner. This year, we published the findings of this research and as a result, the four charrties launched the Ncrflh Star, a vision infom)ed by the report that sets out what needs lo be accomplished. Every child and young person facing cancer receives care that's tailored lo them. They feel infomied and in control, and along Ih8irfamilies can make knowledgeable decisions 8boul their care and futu￿. They feel emptrwered every slep ol the way. facin9 no gaps in support or barners to aeeess. They have everything they need from the beginning ol their cancer journèy, during treatment and for as bng as they need rt 8ftewards. Following thi5. CCLG. Young Lives vs Cancer and the El￿n MxArthuf Cancèr Trust. fomied a Collective Impact CollaboralNe. a collaboration belween the charrt*s that will continue to build on the findingB of the research and work l¢)wards systemic change that wll gee the North Stsr come lo frurtion. We launched further modules of our e-leaming prc¥Jramm lo support the devolopmonl of muttiprofessionals in the earty years of a career in children or teenage and young adurt cancer services. The full sel of nine units will fom) a foundation course called 'An inlroduclion lo cancer in a child. teenager and young adutt, and the remaining vnrts will 811 be avaikble by the end of 2025. The aim is to improve cylions and access lo foundation bèvel lèarnin9 in a limety way, in a format whore learners can choose Iheir own schedule of ￿arnIng. We launched a revised Career and edLKatson fraMeW￿rtI for k*ng4ern follow-up nurses. representing $ignrficanl reviwl of Mmpetencies and ￿reer progression for hohly specialised nursing working in this field. Thi8 $rt8 alongs￿e a number of SWnrf￿8nI careeT and education support resouicey and serV￿e development and delNery resources published by CCLG and widoty u$g118cross NHS ehildren and young people's cancer servKè5. We launched new Th*mbor Spxial Inlerest Grcwps to bri￿ tcgelher èxpert CCLG member8 with an interest in o particular area of work. Our Physical Activity and Exercise SIG focuses on the benefits ol physical adwty and exercise for young cancer patient5 and is working to dovelop evidence-based guidelines lo improve participal￿rt in this area. Our 16-18 SIG is frcused on the particular challenges faced by thi8 age group as they make the transiiion ￿ spockqli81 chiklren's cancer services into efther teenage and young aduK services or aduR servi￿. We continued lo support a number of National Advisory Panels, groups of nat￿n01 experts in particular chiklhood Cancers, to provide expert advtt and treatment guKlance for drffi¢u1i-l￿tr￿aI cases across the UK. We launched a number ol new opportunrties for our profe$$ional members to take up national leadership roles that both supporttheir professional development as well 8$ make contributions lo key areas ofCCLG aclivrty. These include ￿ nursing secondmenl roles lo undertake reviews of key CCLG resources that are widety used by nursing teams across NHS serv￿e$ in the UK. and tsvo Guideline Fellowships that will support our progr8mme of deveknping clinical Ireatrnenl guKlelines and best practice guidelines for chikI￿n and yourKJ people with cancer. rovin dia n05is limes b in sin awaren The signthcan¢e of a delayed diagnosis presents a challenge for primary health care professK*nals, who are required lo triage symptoms that may point to a cancer dragnosi8 and make appropriate onward refèrralg. Envel)pe ID.. 87DOF4SM15>4EB￿B02&7t￿D72S75FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Mony symptoms ass(Kwted with cancer are non-specffK and are seen every day in general practice. whilst cancer diagnosis is seen infrequent￿. Delays in the diagn(Y4tic pathway may well W to Tr￿>18 advanced dtsease at presentation. wtth subsequent greater risk of death, greater morbKIty. and inevitabty. distrust of the medical system. Thore is evidence that lumours presenting in childhoc#J in the UK are larger. al a mre advanced Stage and requife more therapy than those presenting in other parts of Europe. We work lo improve diagnosis limes for children and young people wrth cancer. In 2024.. Wo conbnved our programme of research loch%ing at h¢YW chikIhc￿ ￿nCer presents and the palhw8y810 diagnosis. part of our Child Cancer Smart project. This will culminate in a large Publ￿ awareness campaign, as well a5 the devekjpment of tools for professfv)nals. which will launch in 2025. The aim of Chikd Cancel Smart 1$ lo raise awareness of the svjns and symptoms of childhood cancer, and reduce the lime taken for diagnosis. The Child Cancer Diagnosis St￿. a research projed fvTrJed by the NatK•nal Institute for Hoallh Research INIHRI and CCLG, and joinlty run by CCLG and The UnNersty of Nottingham, moved lo the analysis stage, with the oulccTh$ dLtg lo bo published in 2025. This innovative, nalKJnwide research will gi￿ us, for the first time. an accurate picture of the routes lo diagnosis and where we can develop interventions lo drive improvements. We published a paper ealling for more r8seaTch into popul8lion screening and largeled surveillance for children's and young people's ￿ncer. The paper calls for priorrtisalion ol research which invesligales population screening and targeted $urveillancg for childhood cancer. Population screening would identify at-ri$k children, and targeted surveillance wouhj idenlrfy changes and enable dBgnosis as soon as they dovelop concer. Eadw diagnosis could thon improve suNwal rates and qualty of lrfe for young ￿Ople with cancer. We playèd a leading role in Tunning the second Teenage and Young Adult car￿er Awareness Month m April. This collaboration is an opportunty for charities and the young peop￿ we support lo come together and raise oworeness of the unpue challenges facing this age group. The Iheme for this year was 'empowerment', f¢xusing on supporting young pecple to tske control of their he8hhcar8. More than 20 chaiilies look part in the collaboratson. Ihenin rtin rmation iotosu rt more famil￿ of a child with ncer Looking after a child with cancer can be a scary and lonety eXper￿n¢0 for families. Our goal is lo deliver the right information al the right lime and mae a posrtive dffterence to their daily lives. We continuo lo be the leading prOV￿er of expert-written, award￿innIng and quality-assured information about all aspects of childhood cancer, from diagnosis lo lrfe wthen troalment has finished. In 2024." We Continued lo prowde free information bookbets and ￿aflets lo h05Prtals and directty to familiès during the year. A number of publ￿atIonS were produced, and fvrther existing publicat￿nS were revwed and revised. We produced four issues of our Fopulaf magazine, Ct)ntacl. Feedback on the new fomial and design. launched in 2021. continues to be oveTh¥helmingly wsitile, and Cont* continues to 8UPPOrt families across Ihe UK and around the world. We continued our series of online 'research lak$. aimgd al parents of ehildrèn with cancer land the general publicl, which aim lo explore the world of chiklhood cancer research in an accgssible way, with each episode in the Ser￿ featunng a t￿k from an expert speaker, as well as the opportunity lor attendees 10 ask questions. Recordings of the webinars are made available on our YouTube channel for those unable to attend the INe events. Our closed Facebook group for parent5 and carers of chihjren wrth cancer, which allows members lo seek advice and support from th￿e with $Nnilar experiences. and. uniquely, 'a$k the experts, through posting questions answered by our clin￿1 membership ¢ommunty, continued lo grow, reaching almost 1700 members. We successlulty passed our annual reassessment for the Patient InfOmiat￿n Forum IPIFI PIFTick accredrtalion fof our health informathjn. This qualty standard is awarded followng rigorous asse$$ment of oui information production processes. and demonstrates our ccffimit￿ftt lo reliab￿. expert. high- qualty health information. DO￿￿9n En¥*W ID.. 67DOF45N15>4EBW2>1tKDD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT (CONTINUEO) FOR THE YEAR ENDED 31 DECEMBER 2024 Su ortin and fundi WOfbJOrt Thè Little Prince55 Trust lo fund the best qualty research, with a I￿u$ on findin9 better, kindeT trealmenls. We provide spocialisl advice and fjxpertise, as wfrll as run and manage Iheif resear¢h-funding programme on their behaK. This partnership helps lo minimise dupltation, and share expertise meaning that Uttimate￿ more money is spent directty on research. During the year, the Little Prin￿$ Trust awarded CCLG around £2.3 million to fund innovatwe new research proposals. We lundod a Series ol bloksg￿01 studw pilot grants. in partnership with the VIVO Biobank, lo provide pilot funding for earty career researchers to undertake innovative proj'ects that will advancè our under8tsnding of childron'$ canceis. We fvnded a seriès of nutsing and allied heallh professional research grants for the first lime, supporting key professionals lo get invofved in research, expkjre research ¢aieers. and undertaken research projects that will ftxus on the care and experience of children and young people wrth cancer. Other grants awarded in the year include those for reseatch pr￿eCtS focused on late effects, or the long- lem consequences of c8n¢er treatment. to improve our understanding of the impact of cancer once Irealmenl ends, and how we ean better SUPPOrt SUryNors. We annoL*nced a joint research funding call wrth the Bone Cancer Reseèreh Trust, lo co-fund o number of research projects into primary bone cancers. This collaboration will allow us lo make a signrficanl L4rger investment than either Organisat￿ would be ablè lo do in i8olation, bading to a bigger impact for those diagnosed wrth bone cancers. Following the closure of the Nath)nal Cancer ReSea￿h Instrtute INCRII in 2023. we continued lo support the vital ¢hiklren. teenage and young adutt work prevfv)usty undertaken by the NCRI, prov￿Ing a national slfalegic resource for the developmenl of futu￿ clinul researth. We continued to publish our research bkg. aiming lo make research understandable and accessible lo all thosè in thè childhood cancer community and beyond, induding pargnls. professionals and the general public. The blog shares research concepts and Specif￿ pw'ects in an accessible way, raising awaren9$5 of both the rese8￿h we undertake and of cancer r￿arch MO￿ genefalty. We hosted another Research Discovery Day", lo offer Valuab￿ insight into the research we fvnd to families and supporters. Among the attendees were parents of chiklren diagnosed wrth cancer, suMvor6 and CCLG fundraisers, who were ab￿ lo hear experts laVA al)oul h¢)w they're working to improve the future for Children with ￿ncer. Following the pUblicat￿n of the Top 10 Priorities in Chiklren's Cancer Research. the resytt of a J8mes Lind Alliance Priofity Setts'ng Partnership funded by CCLG and The Litt￿ Princess Trust, we commissioned a'mapping exercise, lo understand the landscape of children's ￿nCer research funding in the UK, collecting data on which of the Top 10 Priorrties are being addfessed and wheTe there are gaps. to help us plan future research investrnenl and ensure all of the prirrties are addressed. During the year. we began devekping ¢)ur new Research Strategy, which will be published In 2025. We have been keen lo en$￿￿ that a wde ran9e of slakehoklers had the opportunty lo input into our strategy, bringing together elinicians, researchers and those wth lived experience of children and young people's cancer, lo ensure that our futu￿ research work meets the needs of all of those groups. As well as considering what research we will fund in the future, the strategy will explore how we can leverage our unique posrtion as a professional association and charty. as well as our convening power and abilrty to build collaborations. to impact the entire ¢hildren and young peop￿,$ canceT research landscape. En¥tbFe ID.. 67DQF4sLk315￿£B￿￿O2￿1C￿D72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES, REPORT {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Fundraisin All of our work is dependent on the generosty of Our SVPP)rters. A programme of fundraising underpins our ability to fvnd research, support Pat￿nts and famil*s, and improve treatment and care for children and young people with cancer. Our Special Named Fund programme continued lo grow. After their cancef experiences. familses somelimes consider setting up their own charty. For many. our Special Named Funds may be a great atternalive. Wè support families lo achieve their fundraising objectives, while taking away the administrative burden of setting up and running a Charity. At the end of Ihe year, there weie approximatety 104 Spec￿1 Named Fund$ al CCLG 12023". 981, each raising funds to support research into a $pecrfbC type of chiklhood cancer. During the year, we rolled out a new internal fundraising strategy. which aims lo ensure we are able lo sustain our income growth and continue lo deliver on our charrtable obiectrves.. funding research. supporting families and ensuring that all young patients receive the best possible treatment and care. The strategy includes investment in fundraising lo devekjp our actNty in key areas, as well as building on previous Investments in data infrastnJctureWh￿h will allow us lo make more slralegic. dal84riven decisions around funtJrai$ing aclivily. We are hugety grateful lo all those who chose to support CCLG, by making a donat*)n. taking part in an event, or organising their chvn fundra￿er during thè year. We are reliant on donat￿n$ lo fvnd our vital work. Wrttknwt th8 gener08ty of thè public. we would not be ablè to continue providing support to children and young people diagnosed wrth Can￿r, and their familiès, nor fund res6arch into childhood cancer. We beI￿ve th81 rt is essentral that we are clear and open about how we raise our funds and about the range of ways peopkn con gel invofved and support our wo￿. People raise money for us in many drfferenl ways. including through taking Part in sporting evenl8. organising events in their kxal communty. or fund¥aising al their p￿￿8 of work. We also provide opportunities for people lo fundraise through provKling access lo pLacgs in key events, such as the London Marathon. and through providing fundraising materials. Our supporters can also sign up lo make regular donations. We Wofk wrth a number of corporate partners. and have receNed support from charitable trusts and foundations, and through grant$ from other ¢haritie$. We do not cary out door-t¢>deo)r fundraising, nor do we use street fundraising lo sign up supporters lo regular dOnat￿n$. Currenlty, none of our frJrKlraising 8CtivitW aT8 cOnd￿ted on our behalf by professional fundraising agencies. CCLG is registgrfjd with thg Fundrak8ing Regulator. We are ¢thmm￿ed to adhering to the Code of Fundraising Practice. During the year, we receNed no complaints about our fundratsing &tNilie$. Regukr updates are provthd lo our board of trustees lo ensuTO that thgy have a good oversight of our ctivities. INANCIAL REVIEW Transaclh?ns for the year ended 31 December 2024 fall into roughty the same categorns as in previoug years. Income generalty consists of donations and fundrai8ing inc£4re, subscriptions (comprising ind¢vidu81 membership $ub$criptson$ and hospital subscriptK)ns for heatth informatK)n), ￿gistratIon fees for meetings and evanls, funding from partner charrties such as The Lrttle Princess Trust to support research projects. and ga¢y income. We are gratefvl to Young Lwes vs Cancer, Teenage Cancer Trust and The Lrttle Princess Trust for Iheii support of Spe¢ff￿ areas of our work. DouJ%gn En¥elr*e ID.. 67DoF45D-315NE8Mf2>1t￿D72B75FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 The major item$ of expenditvre for CCLG remain staff salarie$, professional meeting and event costs, the costs associated wrth the production of heatth inf0m￿tiOn. and the awarding of research grants. Staffing costs represent a significant financial commitment. bul our small, expert staff team is also responsible for the 8ehievement of the majorty ol our ch￿rtable objectNes. Staffing levels are kept under re¥￿w, with the small. efficient team carrying out and coordinating the consNJerable actmties of the charrty. Our overall income decreased by £3.554.882. compared with the year ending December 2023. The majorty ofthis was due lo a reduction in research funding through our partnership wrth The Little Princess Trust, whtch was a pLgnned redu¢lion. The Twsl has been investing reserves over the course of several years. as well 89 making strategic investments in Specif￿ research programme$ (including the Experimental Cancer Medicines Nefvlork IECMCII. and we now expect the inco￿￿ and expenditLtre through our partnership lo remain broadly slable al this level in future years. We saw an increase in donations and legaC￿S of £124,730 over last year, and a Slight increase in investmgnl incom? due to continued hwh interest rates. CCLG has a number of restl￿ted hjnds. Inlefnal records are kept according lo requirements for feslriction, i.e. di¥8ase-specrfic donations for research into a specrfK type of cancer, or donations for a specffic piece of work. The reslricled funds are ring4enced to support specfft projects or areas of activity and cannot be used to support the general running costs of the organisatDn. Expendrture decreased in 2024 by £2,233,875 comparod to 2023. Again. this mainly r8flect8 a reduction in research funded through our partnershp with The Lrttle PnrKesG Trust compared lo the pfevious year. We ended the year with an overall defKit of £493,352. There was a surplus ol unrestricted income of £36.724, compared wrth a deficit of £530.076 in reslrieted into￿ and expenditure. This refleds our previous ¢ynmrtment lo increasing our invotslmenl In research, and the facl the much of our rgstrKled income is reslricled lo reseaich into specrfK type$ of cancer. building over sevwal years unlil Ihere ale 8ufficignl funds available lo invest in high44ualrty, impacllul research projects. The Iruslees continue lo con$Kler the 8ppropri8te balance of financial stabilty and investment in charitable 8etwrty. The COWD-19 pandemic follwd by a period of global economic uncertainty and Inflat￿nary pressure has highlighted thè importance of an appropriate ￿serveS pOI￿y. 11 is important we continue lo hold a level of reserves which can sustain our oCtNrty until we have a fuller pKture ol what the exlemal environment, particularly in respect of fundraising and charitable giving. b)ok$ like in the medium•lern. We have plans in p￿t to ensure CCLG ￿'fil for the future. and our reserves policy will ensure we afe ablo10 meet those plans. Al the end ol the year, we have reviewed our reserves Oicy for CCLG and aim to hold a target level of free reserves lunrestrKted funds less tangib￿ fixed assets) of £250,000 - £500,000, which the Iruslees consider lo be approximate￿ three lo six months of core expendrture. including $tsff salaries, accommodat￿n costs and general Tunning costs, based on the 2025 budget. This represents a change in our reserves poI￿Y from prevKJu5 years, based on future income and expendrture project￿n$, broadty stable land more recenlty increasingl u￿restr￿ell income. and prowdes the flexibilty lo ensure that the charity can invest in charrtible aclivilies. The Twstees cOnS￿ler it prudent to balance the investment of reserves into charitable activrty lo meet the needs of our benef￿lar￿ and fulfil the wishes of our donors and supporters. Having a re5erve5 policy based on a range Tather than a r￿ed figure, as provKsusly, giv8s us the fiexibility to be moré responsive lo appropriate opportuntties for charrtable investmgnt. Total reseNes 81 31 Dg¢ember 2024 were £2.79S.200 {2023.. £3,288,5521 of wh￿h £2,368.518 12023.. £2,896,594) are reslrided and £426.682 12023". £389.9581 are unrestricted. As al 31 December 2024 the chanly's free reserves totalled £399.45212023". £358.9541 wh￿h is comlortabty within the range Set oul in the reserves policy. Given the current econom￿ uncertainty, the trustees consider it prudent to balance the investment of reserves into our eharrtable actNty whilst en$uring Suff￿lent funds are available lo ensure the charity is a 'going concem, and able lo meet its commrtn*nts. The Trustees continue to keep the reserves polity under review lo ensuro that CCLG is'fft for the future,. DorA￿￿n En%*lope ID.. 87D(f4s￿l5S4EB￿￿)2￿1c￿oD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT (CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 Our restricted reserves appear high. at £2,368,518 at the end of 2024. Much of our restricted fundraising income is raised by families, ring-fen¢ed for research into Speerf￿ types of chiklhood cancer. Researeh requires $gnrfi¢ant investment. and thus many of our lunds grthv over th? ￿UrSe of several years before a large sum of money ts awarded in the fomi of a research grant. OLtr restr￿ed reserves comprise a lar9e number of specrfic restncted funds which are ring-fenced lo a spe¢rfic purpose, and therefore cannot b& used for general activi(ies. Levels oflunds are ieviewed on a regular basts and spent on charitable ¥tNrties as soon as sufficient funds are available. Our reslricled ￿SelVeS decreased 81 the end of 2024 compared with 2023, representing our ¢ommrtment lo incfease our investment in research, and we expect lo see a further decrease at the end 012025 as we continue lo support a wtder range of research proj'ects al￿ explore collaborative opportunrties ￿th other funders. nve The Trusle8s pre¥￿U$￿ rev1th￿l our plans for investments lo consider the most approprialo way of managing these, balancing cashtlow, risk and reward. Given the ongoing u￿ertaInty oflhe financial Impact oflhe COVID- 19 pandemic, and the cost￿l-I￿1ng crisis and high inflation. no lurthef aetion has been taken on inveslmènl5. Tho high intoresl rates during the year have retsuft￿ in inueased investment returns in the form of interest on money held in our bank *ccounls. Management a￿nIS are produced foi the trustees, and a c8shflow fore¢￿1 considerabty facilrtates management and predthn of chaTty income. CCLG is also aware of the requiremènt to Cary out a risk revivw of its acliviti88. The InJsle8s revwed the ri6ks the charrty face5 during the year. A Rvsk Regislef is in operation. documenting the systems in place lo miligale those risks, an¢J is kept under review by the Irusltes. UTURE ACTIVI ES All future activities planned are designed lo gnsure Ihal CCLG continues lo fulfil ils objecltvos for children and young people wrth concer. and their families. as the uhimate beneficiarigs. As the membership ol CCLG continues lo grow. so does the aclivrty our members are invofved in. Our $peci81isl netsvork groups continue lo be increasingty actNe. supporting Our actNrties and providing Spec￿1151 adY￿e lo commissioners of healthcare servKes and olhern. The Exèeulive continues to ￿nSKIe[ ways that CCLG can advan¢9 education and professional devdopménl, and share and best prxtKe. During 2024. we have been undertaking a number of Strateg￿ activitie5 to kqy strong foundat￿n$ forthe fLrture of CCLG. These include". A review of our ￿MbershiP bodw ICCLG and Teenagers and Young Adutts with Cancer, TYACI wrth a view to rnerging the into a single. unr¢ed associalion fof the benefit of all chIld￿n and young people wth cancer. Folk￿ing the reww. carried out wrth a wide range of slakeholders, rt was agreed there were many benefils lo this approach. and In November we confirmed with the membership that we would proceed wrth merging the Iwo memberships in earty 2025. At the same lime, we carried out a p￿ce of work Invo￿.n9 a wide range of stakeholders lo understand the perceptions of CCLG. including our perceived sliengths, weaknesses and Potenti￿ opportunrtieg for the organisalion. Key themes included the value of Ouf expe￿'se. our strength as a convenor and leader of collaborations. our insights into the heahh system. and OUT bndge be￿een professionals and patients and their families. The aim of this work was umimatety lo build on our strengths, to improve our positioning and storytelling, and lo raise awafene5s of CCLG and our work, with a long-lem view of increasing support for and income lo the chanty. Thts work, abng wrth the pending merger ofthe professional bodies, resuAed in a deci%ion lo rename the organisab'on and develop a new brand Ihat woukj fu￿11 these aims. As a result, we bègan operating as CCLG.. The Children & Young Peop￿,$ Cancer Association from March 2025. We continued with previousty paused work on developing. building and ￿UnChIng a new website lo accompany the new brand launch. and the make a more accessble online platform for patients and their 10- En¥eknw10.' 67DOF45L1315￿EB￿02&1D￿D￿675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 families, as well as those seeking lo support CCLG. The new website launched alongside the new brand in 202S. Key planned acliwty for the next 12 months includes". L8unching our new Research Strategy. ￿1¢h wll include a Icday operation of the chanty on behaw ol the trustees. The remuneration of key management is rev*wed annuaty and is set against established pay scab&s, benchmarked in comparison with sinilar sized enlrties including both charities and medical professional 11 IfA Dtwlgn Envelope ID.. 67DCF45[k315&4EBMO￿1D$DD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 associations. The ITUStees gNe their time freePy and no remuneration was paid in the year. Detsils of trustee expenses are disclosed in note 12 to the a¢¢ounts. Key Management Personnel during the year were". Ashley BalkGamble Ichief Executive) Claire Shinfield (Director ol Engagerrent) Vicki Brunt (Head of Fundraisingl Sarah Evan$ (Head of R￿arCh} Phil Welsh (Head of Communieations) Jeanette Hawkins (Chief Nurse) Jo Stark (Chief Nurse) STATEMENT OF TRUSTEES. RESPONSIBIUTIES The trustees are responsible for preparirvJ the Twslee$' Report and the financial statemènts in accordan¢e wrth applicable law and United Kingdom Accounling Standards (Unrted KingdcAn G8neralty Accepled A￿OUntIng Practice}. The law appI￿ats￿ lo charities in England & Wales and Scotland roquires the trusleeG to prepam financial slalemenls for each financial year wh￿h give a true and fair wew of the Stale of affairs of the charrty and ofthe incoming resources and application of resources of the chorty for that period. In preparing these financial stalemenl$, the trustees are required lo.. select suitable accounting policies and then appty them consistently., • observe the methods and principkns in the Chorit*s SORP 2019 IFRS 102)., make judgements and eslimales Ihal are reasonable and prudent: $t81e whether applicable attounting standards have been foll¢ywed. $uty'ect to any material d6parture5 dis¢h)sed and explainèd in the financial slatemenls.. prepare the financial statements on the going corKem basis unles8 il is inappropriate lo presume that the charity will continue in operation. The Iruslees are responsible for keeping prcper accounting records that diselosg wfth reasonable aecuracy at any lime the financial position of the chanty and enable them to ensure that the financial slalemenls ¢ompty wrth the Charities Act 2011. the Charities and Truslee Investment Iscotiandl Act 2005, the Ch8ri1ies (Accounts and Reports) Regulations 2008. the Ch8ritY&s Accounts Iscotlandl ReguLqlions 2006 la5 amended) 8nd Ihe provisions of the charrty's conslitulion. They afe also responsible for safeguarding the assets of the charty and hence for taking reasonable steps for the prevenlth and detectNJn of fraud and other irreguLqnti8s. In so far as the Trustees are aware.. there is no relevant audrt infom18tion of whKh the ch81ity's auditor is unaware., arld the Iwslees have taken all steps that they ought lo have taken lo make Ihem$elveG aware of any relevant audft inf0m￿l￿n and lo establish that the audrtor is aware of that infomiation. The Iru5tees are reSponsi￿e for the maintenar￿9 and inlogrity of the charity and financial informatson in¢luded on the chanty's web$rte. Legislation in the United Kingdom goveming the p￿paratiOn and disseminat￿n of financial statements may dffter from legislation in olherjurisdiclions. David Oxnam Chalr of tho board of trusttts Date.. 1PA9-2025 12- D¢Gwiw ID.. 67D0F45[￿3l5￿8￿2￿1L￿D72675Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF THE CHILDREN'S CANCERAND LEUKAEMIA GROUP Oplnlon We have audited the finanual statements of The Children's Cancer and Leukaemia Group {Ih#'charity'l for th8 yèar endèd 31 December 2024 which c4)mprise Ihe slalemenl of financial actmties, the balance sheet, the statèmènt of cash flows and notes lo the finanaal slatements, indudin9 significant a¢¢ounling poliues. The financial ieport*ng framework that has been apF4ied in thw'r preparatKJn is applicable law and Unrted King(lom Accounting Standards, induding Financial Reporting Standard 102 Th& Fin8ncig1 RepO￿.￿g St8nd8nl applioablo in IIK* UK and Republic ol I￿land (United ￿'ngdoM Gen*ralty Attepled Accounts"ng Prath"cel. In our opinion the finanrAal slalements.. 9ivo a Iwg and faif v*w of the stale of the tharty's affairs as at 31 t)fjcgmber 2024 and of rts incoming resour¢ts and appliulion of resources. for the year then ended", hav8 bo&n py0p￿y prepared in accordance with Unrted Kj'ngdom Ganerally Accepted Acc4Junting Practice.. end hava been prepared in xcordance wrth the requirements of the Chanties Act 2011, the Charitses and Tru$l8fj Inveslmonl IS¢otl8ndl Ad 2005 and regulation 8 of ihe Charit￿$ A￿O￿nIS IS¢oUandl Regulatsons 2006. B*•l• for opSnSon Wts conducted ¢>ur audil in accordance with Intemational Standard$ on Audib"ng IUKI IISAS IUKII and applicable law. Our re8pon5ibilth.es under those slandards are fvrther descnbed in the Audrtorfs ￿sPonsIbl11￿"t$ for the audit ol the finanrAal slalements section of our report. We aTtr independenl ol the charsly in accordance with the ethic81 requirements that are relevanl lo our audrt of the financial slatemenls in the UK, induding the FRC'S Ethical Standard. and we h8vg fulfilled our other ethical respon5ibililJes in accordance with these requirements. W8 belie that th& audit *￿dence w¥ have obtained is SUff￿￿en1 and appropriate to prowde a ba$is for our opinion. Con¢lu•lon¥ v•l4tlng to golng conc•rn In auditing the finanaal stalements. we have condLKlod that the trusl•es' use of the golng o)nc•m ba818 01 accounting in the preparation of tho financaal stat•menls r6 8pprow"o1e. Based on the work w8 have pertom)ed. we have not idenlffied any material unc•rtaints&$ relaiing lo evenls or conditions that, individually or ¢olledivety. may c851 signifKant doubl on the charity'$ abilty lo Continue as a goin9 concem for a perlo¢J ol al least twe￿ month5 from when the financkgl statem8nt$ a￿ auth0ri8ed for issue. Our responsibilrties and the responsib￿th$ of ihe Iruslges wilh r•spec4 lo going concern ar• d8sulbed in the levanl Bècl￿)nS ol Ihis rwri. Oth•r Inforniatlon The other infonnation comprtses the information Induded In the tnjslees, oport. other than the finantyal slalernenls and our auditor's report th6r8on. The twslees are ￿SPOnsible lor the other inlormatKJn conlaingd within Ihe trustees, report. Our opinion on the finan¢ial stslemenls doe5 Th)t cover the olher informatson and, &Kcept lo the exient otherwise oxpliatly $laled in our r&port. we do not express any lo￿ of assurance condusK)n Ihèreon. Our respon$*)Iltty is lo read the olher information and, in doing so. considw whelher the other infomiation is m8leri8lly inconsi51enl with the financial slatemenls or our knowledg9 obtained in the cours& of the audit or otherwise appears lo be materially misstaled. If we idenknfy such fflalen81 inconsistenues or apparwl material misstalemenls. we are required to dètemiinè whether this gives fise lo a material misslatemenl in the finanrjal slatemenls themsefves. 11. based on thè work we have performed, we ojndude that therè ts a material misstatement of Ihis other infomalion. we are wuired lo report that fact. We ha￿ nothing to r¥port in this regard. 13- DDtAowJn Enveknpe ID.. 6700F450-315>4EBSBO2>1t￿o7267sF0 THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION INDEPENDENT AUDITOR'S REPORT (CONTINUED TO THE TRUSTEES OF THE CHILDREN'S CANCERAND LEUKAEMIA GROUP Matters on whl¢h ￿ •rn r¢qulr•d to report by exceptlon We have nothing lo report in respèd of the fdlowirvj matter5 in Tel3tion lo vthith the Charities (Accounts and Rfyportsl Ragulalions 2IJ08 and the Charities Accounts Iscotkndl Regulaiions 2((IS require us to report lo you rf, in our opinion.. the infomath?n gI￿n in the finarnyal Slalements b8 ino)nsistenl in any malerial respect with the truslges, report". or the charty has nol kèpt ad•quale arhd proper ac4>)unling records.. or the financial statém•nts are nol in agreement ￿th the accounting records and retums,. of we have not recAved all Ihe infomialion and gxplanalions we reqvire for our audit. R••pon$lbllltle• ol tru•ts As explained more fully in the trustees. r¥$ponsibilrtK*s stslement sei out on page 12. the trustees arts responsible for Ihe preparation of the finanual stateme1￿ and lor ￿l￿g satisfied Ihal they give a true and faif view. and for such intemal control as the truslees determine is necessary lo enable the p￿parat￿n ol financial stal•menls that are fr89 from material misslaloment. whether due lo fraud w effor. In P￿parIng the financial statements, the Irustees ar• rèsponsibl& lor assessing the charity's ability to ¢ontinu# as a going concem, di5dosing, as applicab￿. matters ￿la1¥{l 10 going ¢oncem and Using the going concern basis of accounting unless the truslee$ fjrther intend lo liquldale t￿ thafty or lo cease operatw)n$. or have no realisti alternalive bul to do $0. Audltorf¥ r•*ponilbllStl•• lor th• audEt of th• flnancl*l •tat•m•nts We have been appointed as auditor under section 144 of the Chanties Ad 2011 and section 4411)Icl ol th• Charities and Trustee Investment Iscottandl Act 2CXIS and report in acctyd8n¢e wth regulalv)n8 made under thgse a¢ts. Our objectNes aro to obtain reasonab￿ assurance about whether Ihe fThnrAal statements as a wholg a￿ free from material misstatement, whether due lo hud or trror. and to issue an auditorfs report that includes our opinion. Reasonablè assurance 1$ a h￿h level Of assurance bul is not a guarant8a Ihat an audit ￿ndUCted in accordancg wrfh ISA$ IUKI will always detect a malerial misslatement when it exists. Misstalemenls ean arise from fraud or error and are considered material rf. indiwdualty or in the aggragale, Ihey ￿￿Id reasonably be expected lo influencè the e¢ontsmic decisions ol users taken on th• basis of Ihesè finawal $lalemenls. Irregularrti8s, induding fraud. are M)stsnces of nonwcompliance wilh laws and regulations. Wg d¢$wJn procedurg$ in line wrth our iesponsibililies, oullined at4)ve. lo detect material misstatements in respè¢t tsf I￿egUlarities. including fraud. The extent lo which our procedures are capable of detectmg irregularits'e$, including fraud. is detailod below. Extent to whSch th• audSt wa• ¢onsld•rod e•ybh of d•tscting Irregul4rlti We Identify and assess the risk5 of material misstatemenl ol the financial statèments, whether due to fraud or errtsr, and then design and perfomi audil procedures responsive to those risks. induding obiaining audit ewd&n¢e that is suffiaenl and appropriate to provide a basis for our opinion. However. responsibilty for the prevention and delection of fraud ultimately rests vMih bolh thosè thargeil Tr￿¢h go¥emance and managernent olthe chanty. In thnlfying and assessing risks of material misststement in respect of I￿egUlarli1e$, induding fraud and non- mpliancè with laws and regulations. our proceduTes included the followng.. obtainin9 an und8rslanding of the legal and Tegukltory framework applKable to the thorty by (Xlnsidering the natur• ol thè industry in which the charty operates and enquiring ol managemgnl", and identifying the key laws and regulatK)ns con$thred lo h8ve a direct impact on the financial slalements including the UK ChaTrties Act 2011. Charrtie5 and Trustee Investmenl (Scoilandl Act 2005, UK Generally Accepted Accounts'ng Pradice and UK tax ￿ls18110n." and assessing how Ihe charity is comptying ￿th the applicab￿ ￿gaI and regulatory framewort by making further enquiries of management and observing the charity's ￿ntrol envifonmenl regarding Compliance with iegulations and frau¢J prevÈnlion'. and assessing the susceptrbilty of the charitys finanual $latemen15 to material misslatement, induding fraud might occur, by considering the Èffe(*vèness of Ihe charrty's ac4))unting systems and controls and these were monitored by managèment. ￿ere the risk of malerial misstatemenl was considèred lo be higher in certain areas, fijrther audrt pro￿vre$ were designed to address this increased risk.. and 14- THE CHILDREN'S CANCERAND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE CHILDREN'S CANCER AND LEUKAEMIA GROUP discussing amongst the èngagement team and vthere fraud might occur in the financial statgments and any polential Indicators ol fraud. Audit response to risks of irr•gularlllé* Id•ntifieil Our procedures to respond to risks identsfied indudod the folhywNIg'. rforming audit work over revenue recognibon indudin9 analykal procodufes and $ub$lanlwè lèsls of detail of a sample of revenue transac1￿$., and reviewing finanraal stalemenl disdosures and t&sting to suppot*"ng doCUmentat￿n to assg$s compliance with applicable laws and regulalions.. and enquiry ol charity staff responsible compliance lo id&nlrfy any instsnces of non-compliance with laws and regulations., and enquiry ol management, those thaTg8d wilh go¥emanc¢ and other relèvant parti88 around actual and poltrnlial litigabon daims., and r•vi•wing min￿e$ of Meet￿95 of ihose charged with govemance, and performing audit work over th¥ risk of management Override ol controls, induding lesling of joumal gnlries and oth&r adju$lm¢nl$ for 8ppropnaleness, evalualing the t￿SInesS rational& of significant Iransa¢b'on$ outside the normal ¢ourse of business and remewing accountulg e$tsmal¢s for bias". and cornmuni¢gling i¢Jents"fied laws and regulations and potentsal fraud risks to all engagem8nt team members and 8$se$sing whelhtrr there are any indications ol fraud or non-¢ompliance wilh laws and rggulalions throughout Iht audrt. Because ol the inherent limitation$ ol an audit. there is a risk that we will not delect all irregularrties. including Ihos& loading lo a malerial mi$slal&menl in the financial statemenls or non-comph'an¢¢ wrth regulalKJn. This risk in¢rea$#5 the more that ¢omplianc8 with a law or regula1￿ is removed from Iho $v&nls and transactions refl8¢led in the financial slalemenls. as we will be less likety to becom8 aware ol 1rt$18rKes of now￿MplianCe. Thè risk is also gre8lèr regarding irregularilies 0￿￿rTIng to fraud ralhof Ihan error. as fraud involve$ int&nlional concealment, forgery, ¢olus￿n, omission or misr•pr•wnlalion. A furth81 de$¢riplion of our responsibiliti'es is available on th8 Finan￿81 Rgporting Counc41's w9b$￿e at.. http8'.11 vAvw.fr¢.or9.uklaudrtorso$ponsitslities. This d•script￿n forns p¥rl of our ¥udrtorf$ re￿1. Us• of our Y•port This report is madè sO￿ty lo the ch8rity'$ Iwslees. as a body. in accordance wlh Part 4 of the Ch8fitle$ IA¢¢ounl$ and Reports) Regul8lions 2008, and Regulation 10 01 the Chanties Account$ Iscollandl Regulafyons 2Ix)6. Our audlt work h8$ been undertaken so Ihat we mighl slate to thè ¢h8ritys Iru$lee$ ihose matters we are required to $18le lo them in an auditors, report and for no other pU￿OSe. To Ihe lullesl extent perniitied by ￿. we do nol accept or assume re3pon5ibilty lo anyone other Ihan Ihe ¢hanty and the tharity's trustees as a bofly. for our audit work, lor ihi5 report. or for the opinions e have lomied. Newby C4•tleman Charttred Accountants StatLrtory Auditor West Walk Building 110 Regent Road Le￿$ter LE17LT 19 September 202S Newby Caslleman LLP is eligible to act as an audrtor in temis of sedion 1212 ofthe Companies Act 20CE. 15- DooJsvJn En¥elopo ID.. 67DoF45￿3lS￿BMo2>1t￿D72675F0 THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2024 Unr•strict•d R•strlci•d funds fvnds 2024 2024 Total Total 2024 2023 Ineom• from: Donations and legac4es Charitable adMI￿S Investments 953.823 463,611 69.931 627,879 1,581,702 1.456,972 2.809.187 3.272,798 6,966,184 69,931 56,177 Totsl 1.487.365 3.437,C66 4,924,431 8,479,313 Exp•ndlturn on: Ralsin9 funds Charitable act1w1￿S 342.891 51,712 1.103.627 3,919,553 394,603 348.007 5,023,180 7,303.651 Total 1.446,518 3.971,285 S,417,783 7,651.858 Net Incomlnglloutgolngl r••ourcM b•fov• transf•r• 40,847 1534.199) 1493,352) 827,655 Transfers beh¥een fvndi 14,1231 4.123 N•t Incom•ll•xp•ndltur•l forth• y••rf N•t mov•m•nt In fund• 36,724 1530,076) {493,3521 827.055 R•con¢lllition ol lund• Total funds brought fon¥ard 369,9SB 2.898.594 3,288,552 2,460,897 Total fund• canl•d forward 426,682 2,368.518 2.795.21JO 3.288,552 16- Dmign En￿knpe ID.. 67[x)F45￿75>4EBg￿1CffjDDn875FD THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION BALANCE SHEET AS AT 31 DECEMBER 2024 2024 2023 Fixed ags•ts Tangible assets 14 27.230 31,004 Curr•nt a$$•ts Stocks Debtors Ca8h at bank and in hand 15 16 46.019 3,387.399 4.480,787 55,(E1 5.373,880 5.105,709 7.914,205 10,534,650 Llabllllb•s Credilois.. omounls falling due wrthln o year 17 (3.704,0811 14,893,819) N•t curr•nt a•8•ts 4.210.124 5,840,831 Totsl *11•ts l•M curr•nt Il•bllbtl•s 4.237.354 5,871,835 Cwdbtorn: amounts falllng aft•r more than on• year 11,442,154) {2.383.283 Totsl not ••s•ts 2.795,2Tr) 3.288,552 Th• fund• of tho ¢harlty Restriclgd funds Unrostricled funds 20 21 2,368,S18 426,682 2.898.594 389,958 Tot*1 ¢h•rfty tund• 2.795,2LX) 3,288,$52 l8-￿2025 The finanual slatements warè approved and authorised for is$ut by the board of IrLtsto8s on ........ ................ and are signed on 11$ b¢haW by." Oavid Oxnam (Chair of Bo8rd of Trustees) Truste• The notes on pays 19- 33 form part of these finanr￿al slatements. 17- DoGwign En￿1¢￿ ID.. 67D(*45￿1S>4E8￿23-lL￿DD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 2024 2023 Cash flows from op•rnlSng actl¥ld•* Cash (absorbed byllgeneraled from operations 1689.3991 1.026,714 Inv••tlng actlvlti•i Pur¢hase of tangiblt fixed assels Investmènl income received {5,4541 69,931 12,5921 56.177 N•t cash g•n•rnt•d Irom Invmtlng actJ¥btl•• 64,477 53,585 N•t caih u•ed ln fin•nclng •cthiltl N•1 {d￿r*•￿I￿n¢￿•1• In c￿h Ind ¢••h •quSv•l•nts {624.922) 1.080.299 Cash and cash eqw*nt$ al ￿gInnIng ol year 5,105,709 4.025.410 Ci•h Ind c*•h •qulv•l•nts at •nd of ye•r 4,480,787 5,105,709 18- l)oGuww EnvekJFe ID.. 67DOF45Lk315>4E8W2$1t￿Dfk675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 A¢¢ountlng pollcl•* Charity inforn)atlon The Children's Cancer and Leukaemia Group is go%*rned by its Constitutw. 1.1 Basls of propar4tlon The charity is a PLtbli¢ ben8fi1 entity as defined by FRS102. These finantyal statements have been prepared in accordan￿ vrith." The Financial Reptsrting Standard applicable in the Unrted Kingdom and Republic of Ireland I"FRS 102.1. Ac¢ounting and Reporting by Charrties.. Ihe Statement of Recnmmended Practsce for charrties applying FRS 102120191, Ihe Charibes Act 2011, Ihe Chanti85 and Truste• Inv$$tm$nl (Scollandl Act 2005, and UK Generalty Accepted ArKounting Practice. Thg finanaal slal•m•nl$ ar& prepared in st¢ding, which is the fijnctional cuffency of Ihe ¢h8rlty. Monètary amounts in tht8e financlal statements are rounded lo Ihe nearest £. The finanrial statements ha￿ been prepared urmler tho hist￿1￿1 ￿$t ¢onV•nI￿Th. The PTincApal ac£ounting polid&s adopt•d ar• s•t out bebw. T￿ have bgen o)nsis1onl￿ appl*d. 1.2 Golng con¢•m Al th& tim¥ ol approving the financial stslemenls. the Iruslees have a Teasonable expectation that Ihtr charity has adequate reSour￿S lo conlinue in operational existence for Ihe fore5e8ablè futurg. Thus the ITUStee5 continue to adopl Ihe going Conc￿ basis of accounting in pr•paring th• finandal $talem•nls. 1.3 CharEtsbl• lund• Unre$lrid¢d ftjnds are 8vwl¥bkn lor us& 81 the disuets.on of the trustees in furiheranc* of Ihelr ch8rlt#ble objectives unless the funds have betn deS￿nated lor olher purposes. Reslrlded funds art ftjnds whth are lo be used in a¢¢ordance with sperAfic restrictions imposed by donors or whi¢h have been raised by the ¢haiity lor particular purposes. The cost ol raising and administering suth funds are charged against the 5peafic fvI￿. The aim and use of each Teslrict•d fvnd is sel out in the notes lo the financial stalements. 1A Income recognldon In¢ome is recognised when the chanty is legalty ent￿ed to it after any perfornianc8 o)ndrfions have been mel, the amounts can be measured relrébly. and it is probab18 Ihat IT￿offie wll be recefved. Cash donations arè recogniyed on receipt. Olher donat￿nS are rec(*Jnised On￿ the charlty has been notified ol the donation, unless performanc4 conditions requi￿ deferral of the amount. Income lax recoverabk8 in relation lo donat￿nS received ￿der GIft￿.d or deeds ol covenant is recogni$ed al the b.me of the donation. For legarAes, income is Tecogrised and induded in the fmancial statomants when all of the follo¥Mng crileria are mel.. the charity has entitlèment to funds; any perf0rnar￿ conditions attachéd to thè itwnls) of income ha￿ been mel or are fulty within the control of the charrty". thèrè is sufficient certainty that re¢eipl of the Ir￿ is cons*Jered probable., and the amount can be measured rdiabty. ere legarxs have been noIrf￿d to the charity but Ihe uiteria for incoTh recognrtlon have not been met, then the legacy is treated as a contingenl asset and disdosed rf mat&rial. 19- DcaA8ign En¥eW10'. 67D0F45N1534EBW23-IC￿DD72675Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN ANDYOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 A¢¢ountlng poll¢l•• (Continued) Income from charilablo aCtivit￿S irKbJdes irKomg r8ceNed from grants. registration fegs for meeJngs, member subscripts'ons and publieatson paym&nts. Su¢h in¢ome 1$ fecogni5ed at fair valuè when Ihg charity has enlitbmenl aftgr any perfornan¢e condrtK)ns have been mel. it is probable that the income will be rèc8ivèd and the amount can be measuTed wth rdiats"lity. 11 entitlefflent is not mel. thon the amounts are delerred. Invtrslmtnl irKome is eamed through holding assets lor invesimont PLtrposes. 11 ¢ompriso8 bank interest and is recognised on an accruds basis. 1.$ Expend6tur• r•cognition All expènditUf•, including the aw¥rdity of grant$. 18 accounted for on an accnJals ba$18 and has been 8ssth&d under heading5 that aggregate al costs relaling to the category. Expenditure is Ter￿gnised when there its a legal or conslruclive obligation to make paym•nis to third part￿$. rt is probab￿ Ihal settlement will be required and Ihe amrwjnt of the obligation can be measured reliauy. 11 bs recognised under thé followin9 headings.. Costs of raising funds include$ costs Incurred in seekrng donalh)ns, grants and legadès, websitè ¢osls and a￿er11$In9. Expenditure on ¢haritabla acIl￿ti￿3 indudes r88earth, odueat*)n81 aclmllgs and professional as$¢xith'on *divrties lo furlher the delivery of the objectives of tho ¢harity. 1.1 Support costs Support Costs are Ihose th81 assist the work of the charity bui do not direclly represènt ¢h8rrtable activities and ¢osls ol raising funds and include office costs. govemance costs and admini$lrallve payroll costs. They are incurred directly In support ol expendrture in line wrth the objectivès of the ¢h8rty. Support costs ar• allocaled lo costs of raising lunds and 8xp8nditure on ¢hariiable acb"vrties on a ba81& consislenl wlh ol the resourrEs. The onalysis ol these costs is indud8d in notg 10. 1.7 Tanglble flxed a••ets Tangible ffixed assets are measured al c05t. nel ol deprerAat*Jn and any imp8imitnl10$8es. Oeprecialion is recognised so as to wriio off th8 cost of assgtslgss their re$idu*l value5 over their useful lives on the following bases.. Computer eqvipmenl, fumiture and r￿l￿r&S 10 years 1J Stockn Stocks indude merchandise st(xk and edu¢alK)nal literature. Sl¢)cks thal are ￿ld for résale are staled al Ihe lower ol ¢ts$18nd eslirnaled selling price. StcKks held for distrsbulion as part ol the ¢harity's actiwties are valued al their potentsal, which the tharity consmlers to be the co$1 of the material5. 1.9 Cash and cash equi¥•l•nts Cash and cash equwalents include cash in hand. ¢*posits held at cam with banks, other short-term liqu investment5 Wlth original maturities of three ffKJnths or less. 1.10 Flnancknl Instrum•nts Financial instruments are recognised in thè charl￿S balar*e Sheet when the charty becomes paty lo the contractual provis¢ons of the instrumenL Dèbtors and uedrtors wrth no slated interest rate 8rKI recewable or payabfe within one yè8r are mea5UTed al transaction pii¢e. Any1055e5 art5ing frorn impawmenl are recognised in the Statement of Finanaal Activities. -20- OLwn En4*bpe ID.. 67DCf45M1S34EB￿23-1D￿72G75FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS ICONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Ac¢ountlng poll¢l•• (Continued) 1.11 Employw bon•fits )èn èmployees havè rendered service to the djarity. short-lerm empkjyee b&nefil$ to which the employees are enlilled are re￿nISed at the undiscounled amount expected to be paid in èx¢hangtr for that seThic8. The cost of any unused ￿IdaY ￿till8m￿l is r8cA)gnis¢d in th• period li whth the employeo's 5orvkes are received. Temiinalion bon•fit$ 8r¢ r¢wnise(l immodkglety as an expense when ihe thanty 1$ dgmonslrably cofffflitt8d 101gmiinate the employrnenl ol èn employee or to pro¥ide lermination ténefils. 1.12 R•tir•m•nt b•n•fft* PaymÈnt8 lo defined contribut￿￿ rebrement benefit schemes ar8 char9•d as an ex￿￿$# as they fall due. Crltlcal •¢¢ountlnq ￿tImOt•* •nd Judomwits In the 8pplical￿ of the chanty's 8cts)unting poliaes, the twslees are required lo make Judgements, ￿tim9te8 and assumptions about the carryin9 amount of assets and liabililie$ Ihal are not readily appaienl from olher sources. The estimates and assocAted assumptions are based on hi$1orKal experience and olher fa¢ltys that are considerad lo be relevanl. Actual resutts may drfer from these e$lirnale$. Th• e8lim8les and undertylng a$sumplion8 are re¥iewed on an ongoing bo$is. R•vi$lons lo arLountiThJ &$limales are re¢ognised in Ihe perb)d in whith the estimate is revised where the revision affect5 only that period, or in Ihe period of the reVis￿n and future periods where tho 1ovi*on alled$ both current and fvlure periods. K•y •ourc•• ol tttlmatlon une•rt*lnty The eslimates and assumptions which have a swJnffi¢anl risk of cauwng a material adjuslmant lo Ihe carrying amount ol assets and liabilit*s aio as fomows". Allo¢•Oon ol Jupport cos1* The allocation of support ¢o$ls 1$ s•nsilNe lo ¢hanges in the level of work undertaken on each acliwty by the charily. The allo¢otion 1$ reassessed annu81ty 8nd amendèd when necessary to reflect current eslimales. Income from don•tlong •nd hg•cie• Unr•strlct•d R•strlctèd lunds funds 2024 2024 Totsl Llnreslrided lunds 2023 Restriclgd funds 2023 Total 2024 2023 Don81ions Legaa•s 626.417 327,4C 627.879 1,254.296 327,4( 622,960 129,981 703,031 1,325,991 130,981 953.823 627,879 1,581.702 752,941 704,031 1.456,972 21 DoAJsvJn En%kn ID.. 67DOF45M1SM8￿2￿l(￿O72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 In¢om• from ch•rltabl• a¢tfviti Unrnstrkt•d R•strl¢t•d lunds funds 2024 2024 Total Unreslricted Restricted funds funt15 2023 2023 Total 2024 2023 Registration lees for meetings and other project expenditure Member subsixplions and publication payments Grant In￿Me for research arh1 operations CLIC S8rg¢nl thief nurse funding 238,380 11.750 250,130 128,757 28,299 155,lJ56 152,428 152.428 153,279 153,279 72,803 2.701.486 2.774,289 72,359 8.￿,385 6,578,744 95.951 9S.9S1 79.085 79,085 463,611 2,809.187 3.272.798 352,395 8,613,769 6.966,184 Incom• from InvKlm•nts Unr••trlct•d funds 2024 Tol•l Unrèstrict8d Jnds 2023 Total 2024 2023 Interest 69,931 89,931 56,177 56,177 Expondltur• on rnb¥lng lund• Unr•strbct•d R•strlctsd funth funds 2024 2024 Tol*l un￿61￿Cted fvnds 2023 Restrid&d funds 2023 Ttstal 2024 2023 Fundraising plarfomi fees WebsTte Fundraising, marketing 8nd publiaty costs Support Costs Inole 101 26.222 2,293 26,222 17.227 30.237 3,567 30,237 13,041 14.934 9,474 138.031 176.345 36.778 174,809 178,345 110.813 167.166 26.750 137,563 167,166 342.891 51.712 394.603 311,783 36.224 348,007 DocLtslgn En¥efvJpe10." 67DOF45M15>4EB￿2>lD6DD72875FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Expendlturn on charlt*bl• *ctivltS01 Aetlvlll•s und•rt*ktn dirncty Not• 8 Grnnt fundlng Support Costs Totsl 2024 Total 2023 Not• 9 Mol• 10 Support for research Information lor patients and famllles Improving treatment and cafe 378,818 3,404,299 66.594 418.206 184.826 3.967,943 6,381,705 275,496 342.090 331,351 294.941 713,147 59J,595 863,618 3,404.299 755.263 5,023,180 7,303.651 Unreslrfcted frjnds Re$lricte(I funds 1.103,627 950,732 3.919,553 6.352.919 5.023.180 7.303,851 ExP•ndI￿r* on •¢tlvltl•s und•rt•k•n dlrn¢ty Support for InfOn￿tIOn Improvlng r￿arCh lor p•tl•nts tr•atrn•nt and famlll•¥ •nd ¢•rn Total 2024 Total 2023 Staff cosls Other lumour spocific expenditure Contact magazine expenses Other publication Èxpans68 Website Cost of m•ating$ Travel expenses Membership SLFPPOrt costs Other expenses 205,335 156.255 205,335 156,255 20,306 20,446 68.912 344.837 16,893 24,094 6,540 189,557 42.095 21,107 32,169 52,183 266,303 13,906 11.767 8.782 20,306 20,448 25.842 17.228 25,842 344,837 16.893 24.094 6,540 378.818 66,594 418,206 863,618 635,849 Docthlgn En*knpe ID". 67DOF45Ck31S￿E6￿BD2>1D60D72675Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Exp•ndliur• on grant fvndlfftg Support for rnsearch Totsl 2024 Total 2023 Grants lo institutions.. UniversTiy o18irmingham Universty ol Surrey Nwcaslle Universty UCL InstitLrte of Child Health University of Sheffield Universty of Notlingham Universty of Biisld Great Omiond Slraet Universrty of Southampl Univer5ty Hospital ol w￿e$ Unlvgrsty of Glasgtrw Universty ofyork Uni￿rSty ofcambn'dg Inslitule of Cancer Research Ufiiversty ol Leeds Universty of Oxford Universty CoNeg• C Swansea University King's Cdlege London The Open unI￿r$Ity Brunel Univer$ty London Leeds Teaching Hospitals NHS Twsl Universty ol Edinburgh Universty of Sussèx Univ&rsty ol Liverpool Imperial Coll8ge London Sheffiekl Children s FOunda1￿n Trust Universrty Hospitals Brisld and ￿slOn NHS Trust Universrty of East Anglia 350.207 112,216 1474) 345,890 350,207 112,216 14741 345.890 942.299 437.890 409,691 213.725 287,497 321,339 81,543 61,C69 702.3 81.543 81.069 702,390 222,463 133.114) 216.831 252.882 493.268 186.225 61.556 99.701 4.950 230,943 74.458 (94) 133,114) 216.831 252.682 493.288 186,225 61,556 99.701 4,950 230,943 74 458 1941 124,806 559,734 248,355 494,146 98,468 199,399 52,097 352.568 104,631 175.990 249,909 170,788 299,991 19,949 19.743 124,360 19.949 19,743 124,360 3,404,299 3,404,299 S,963,846 The tharty awards grant$ for Speufic research proie¢As to vaiious institulions. as part of the* tharitat4e activities. Negati￿ amounts r9pro￿nI ￿ under$rw￿ on giants We￿U61Y rnade, returned to CCLG. -24- DO(￿$¥￿n En¥*e10.. 67DLF45t￿3t5￿IEB￿tr￿l￿072675F0 THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 10 Exp•ndltur• on •upport eo•ts Bas1* of allocation 2024 2023 Staff costs DeP￿ClaI￿On & k)ss on dispo$o1 Oc¢upan¢y expenses Po$ta9e Staff training Professional lètrs 716.066 9.228 131,991 15,896 8,571 49,856 653.872 14,074 143,429 14,253 10,205 35,289 "11 931,608 871,122 Analysed be￿￿en Raising lun¢J$ Charitable acliviltfjs 176.345 755,263 167,166 703,956 931,608 871,122 .1 Support ￿$1$. gXdL￿ln9 g0veman￿ costs, have been albcated as follthys: Cost olr8ff$ing lund$ 20%12023- 20%} Charitable &Glivili&s Support for researc* Information for patien15 and lamilltrs Improving treatment and car8 20%12023- 20%1 30%12023- 30.hl 30%12023- 30%> .2 Professional lees indude 90¥gman¢• costs of £49,856 12023 - £35.289). G9veman￿ costs have beèn allocated as lollow$.' Ch4nl4ble a¢lwits"8s Support for research Information for patients al￿ tsmilitis Improving treatment and care 17% {2023- 17%) 22% {2023. 22%) 61% {2023- 61%) The amount ¢har9ed lo the SOFA in rgspe¢l of a(*Jitorfs r￿nu￿rat￿)n w8S.' 51alutory audrt £10.14012023- £9.780 - other servi￿$ £1.38212023- £989) 11 T•x*tlon The chawty is exempt from laxolion on its 8clMbes be¢ause al its ino)me is aP￿￿led for ¢harita￿e purposes. 12 Trwtee• None of the trustees lor any wrsons ¢onnected with them) received any remuneratlon or berths during the year. -25- Do(JJsign En¥dcpe10.' 67Dcf45m15￿EBwf￿1D6DD72675Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 13 Employ••• The average mnthty number of emph)ye8s during Ihe year was: 2024 fr4umbgr 2023 Number Total 24 22 Employm•nt emts 2024 2023 Wages and salaries Social security costs Other pension Costs 769,767 75.889 75,745 709,013 68,378 66,038 921,401 843.429 The number of em￿oYeeS whose ￿n￿￿1 remuner81ion lexduding Pen8￿n conlributionsl was moro than £80.IM) 1$ as folows: 2024 Numb•r 2023 Number £60,001- £70,OCQ £70,001- £80,OOJ £100,001- £110,000 R•rnun•ratlon of k•y manag•m•nt p•rnonn•l The remuneration of key managemenl personnel. is as folknvs. 2024 2023 Aggregate compensalw)n 377.924 300,774 DoMlgn Envebpe ID.. 87D0F45f￿31s￿EB￿2&lD6oD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 14 T*nglble fixed assets Computer tqulpmen( fumituv• and flxturns Total Cost At 1 January 2024 Addition5 90,030 5.454 90,030 5,454 Al 31 Dtcember 2024 95,484 95,484 D•pr•¢latlon and ImpaSrm•nt Al 1 January 2024 Deprgciation Charg￿ in the year 59.026 9.228 59,028 9,228 Al 31 December 2024 68.254 68.254 Carrylng •mount At 31 December 2024 27,230 27,230 Al 31 D0￿Mber 2023 31,004 31,004 15 Stocks 2024 2023 Merchandise sto¢k Educational litfjfalure 23.412 22,807 31.790 23,271 46.019 55,061 -27- Docusign Envelope ID." 67D(F45tY315>4EB&B02>1fknDD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 18 Debto 2024 2023 Afflounts falling within one y••r. Tradè debtofs Grant debtors Rent deposit Prepayments and accrued income A¢¢rued legacy in¢ome 25,29B 2.239,464 18,6ty) 238,554 283.51XJ 19,856 3.512.427 16.200 150.076 138,500 2.805,416 3.836,859 2024 2023 Amounts l•lllng du• 4ft•r moro th•n on• y••r: Grant debtor8 $81.983 1,537,021 Total d•btorn 3,387,399 5,373,880 17 Crtdltorn: •mounts f•lllng du• wlthln on• y•*r 2024 2023 Deferred income Tr8¢Je creditors Grant cr&dilo Accruals 32,241 8,729 3,622.339 40,772 19.559 18.318 4,821,058 36,886 3.704.081 4,893.819 Deferred income irKludes in¢ome reeei¥ed in resped of meetings lo be held in the next finanrAal yoar. 18 Credltorn: •mounts 14lling due •ft•v morn th•n one y¢•r 2024 2023 Grant creditors 1.442,154 2,383,283 19 R•tlr•m•nt ts•￿fft •chwn•4 D•fin￿ eontrlbutlon •th•m•s Th8 ¢harily operates a dthed conlribulion penwn scheme for al qualrfying empbyees. The 8munl of Ix*nln"bution re¢ognised in un￿t￿¢¢t￿ expendrture was £75.746 {2023- £66,038). -28- Do￿ts1￿ En¥doFQ ID.. 67DCF451>315￿EBW2>1D6DD72675F0 THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 20 R•strict•d funds Th8 incom8 funds ol charity Indude restriL#￿ lunds whith comprise the folowing unexpended balances of donat￿n$ and gronls W¢J on Iwsl lor 5peafic purposes.. Mov•m•nl In fund• I￿orn• Exp•ndlturn Tr•n81or• B•Lync• at 1 January 2024 Balance at 31 D￿6mbar 2024 Turnour spe¢fflc funds CCLG Prize General research fund Adam Hay fund CCLG Senior Membef8 Group PODC POTG The Litlle Prfnc8s8 Tru81 furKI Treatment Guidelines fund TYAC Lisa Thaxter Child C¥n¢er Smart PORT CCLG Research Nthork Partner Charity Neuroblasloma NuT8ing Group PODC - Iraq Fund Young LNe5 vs Cancer Chitif Nurse Funding Heatth InformaticA) TYAC General Restri￿¢{1 TYAC Research Projects Restricted Fund 1,805,293 1,LThA,365 11,072,784> 1,538,874 5.670 11,262 10.250 15,920 11,262 6,850 915 2.156 10.170 6.2fxJ 2,314.140 614 21,632 37,786 420 (5,865} 116.4491 12.314.140) 2,100 4.123 6,200 614 2.040 35,190 420 119.5921 12,5961 15.( 15.OCQ 1.500 7.891 9,694 12,8531 2.332 16,920 79.376 181.1191 589 16.920 1,000 86,496 646,131 66,496 1,102,398 1456.2671 2.898.$94 3,437,C {3.971,2651 4,123 2,368,518 -29- OorJtskJn En¥T￿pe ID". 67DOF4S[￿315>4EB￿2￿1CwD7￿75Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 20 R•strl¢t•d lun Iconllnuodl IDv•nwnt In lund• Incom• Exp•ndltur• Tran•f•rs Balanc• at 1 January 2023 ￿#￿n¢t at 31 ￿cember 2023 Tumour speofi¢ fvnd$ CCLG Prize General research fund Adam Hay fund CCLG Senior Member8 Gmup PODC POTG The LrtNt Princess Twst fvnd Treatm•nt Guidelines lund TYAC Lisa Thaxler Child Cancer Smart PORT CCLG Res¥ar¢h Netsvo Parlner Charty N8Ufobla$toma Nursing Group PODC - Iraq Fund Young Live8 vs Cancér Chwf Nurse Funding Health Information TYAC Genef81 Reslncted TYAC Resear¢h Projects Reslrided Fund 1,573.167 805,435 1773.3091 1.605,293 364 5,670 11,262 3,180 11.222 2.4 5.896 954 10.960 6.200 4,510,486 614 36.632 38.105 420 6,850 2,156 6,200 614 21.632 37,786 420 18,8041 14,510.4861 115,0001 {319) 652.188 1652.188) {9.OC¥)} 10,5CiI 8,384 1,500 9,694 1,310 5.948 16,920 83.309 12,X 186,92$1 {12,3WI 2,332 16,920 66.496 1,102.398 165.378 1,237,832 1320,8121 1,969,937 7.317,8(Kl {6.389.1431 2,898.594 Transfers have been made into restricted funds from unrestricted fvnd8 to unde￿Trte a cash defityl on 8 fijnd. Tumour $p•¢lfic funds R¥presenls income received from donors with a $pg¢ifi¢ request thal the fvnd5 ar& (tsgd in support of grants for a p8rticular lurnour type. CCLG Prbz• Represents income receiveil from donorn lo fijnd the CCLG Prize. G•n•rnl rns•*r¢h fund Reprasents income received from doTr)rs wilh o $peofi¢ request that the funds are used for researth purpo￿$. Adam Hay fvnd This fund has been eslablishÈd to ¢onthnue work done by the Adam Hat's charity {which merged wth CCLG in 20111 in neuroblastoma research anil psythdogical 5UPPOrt for children and familie5. CCLG S•nlor M¢mbern Group Reprasants in¢ome received from Ihe Senior Members. Group to be used for Iheir actMtse$. Docuslgn ErwekJFe10.. 67D￿45[￿lS>4EB￿802SlL￿DD72o75Fo THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 20 R•strlet•d lund8 (cont1n￿dI po Represents income receNed frorn donors to be usgd for the Paediatri¢ Oncology in Devgloplng Countries {PODCI. POTG Represents In￿me ￿ceIved Irorn d￿Or3 to be used for the Paediatri¢ Oncology Trainee5' Group IPOTGI. Th• Llttl• Prlnc••i Trust fund Represents income received frorn The Litlle Princess Tnjsl lo fund luture instalments of r&search grants awarded. Trnalm•nt Guld•lln•8 fund Represents a grant rècewed lor Ihtr dèvèkipment of rare endocrine tumour guideliM$. TYAC Th*xt•r Represents income receNed for providin9 and supporting eduCat￿$n and training to professionals Working in the field olteenage and young adutt cancer. This was prewously a restricted fund in TYAC and has transferred lo CCLG as parl of Ihe do$uf8 of TYAC, wth the same TeSln"dions maintsined. Chlld C*n¢•r Sm•rt R&presenls Income r￿r￿ed lor a research programm&, swKleline d8¥elopment and awaren&s$ ralsing focusing en earlier diagnosis ol childhood cancer. PORT Represenls income receiv&d for Ihe Paedialri¢ On￿Y Rtsference Team. a group of parents ol children wrth cancel who revsew din1￿1 tri￿ and other rtsearch infonnaiion to ensLtre rf is appropriato for chibjren wjth cancer and their fomili¢s. CCLG Ro*•ir¢h N•lwork P•rtn•r Charfty Raprè8ènt8 income researc* frijm other charIt￿S to fuThJ researth proie¢t$. N•uroblastoma NurnSng Group Represents in¢om¢ le￿1¥e4 lo support the Costs of running the nathjnal neuroblasloma nursing group. a group ol CCLG member nurs¢s with a $pety¥l interest in neuroblastoma. POOC - Iraq Fund Repre$enls don81ion5 Tecei¥ed lo specikalty support wort to improve th& Iroatmenl and care of ¢hlldren with cancèr in Iraq. Young Llv•s v• Canc•r Chb•f Nurn• Fundlng Funding for the Chief Nurse role and a$so¢ialed proje¢as. Hèalth Infornmtlon Funds rec*fftd lo $upport the prodU￿th ol healih intofflHtion for patients and famlles. TYAC G•ner41 R•strlcted Fvndra151ng and donations to suppori wort speaficalty lor leenagets and young adulis with can¢gr. TYAC R•s•arch Income restricted to support resear¢h projeds into teenage and young adult cancer. Prol•cts R•strlet¢d Fund• Income restricted IO SUPPOrt speryfic projects indudiThJ wort related to research. 31 DO¢￿￿n Envekjpe ID.. 67DCf45fM15UEBW2&1DeDD72675FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 21 Unrestricted fvnds Mov•m•nt in funds Incom• Exp•ndttur• 8•hnce •t 1 January 2024 Trnnsf• Balanc• at 31 Do¢•mbttr 2024 Gen•ral fund$ 389,958 1.487.365 11,446,518) 14.123} 426.682 Mov•mont In fund• lThcom• Exp•ndltur• B•lanG• al 1 January 2023 Trnn•f•rn B•l*n¢è 4t 31 Dec•mb•r 2023 General fiJnd5 490.960 1.161.513 {1,262.515) 389,958 22 Anaty$h of n•t au•ts b•tw••n fun Unmtrl¢t¢d R••trlet•d funds funds 2024 2024 Tot*1 2024 Fund balances at 31 O•c•mb•r 2024 4rn rnpr•••nt•d by: Tangible assets Current 8sse1511llabilrt￿$l Long tem) liabilities 27.230 399.452 27,230 3,810,672 4.210,124 (1,442,154) 11,442,154) 426.682 2.368,518 2.795,200 Unmtrlct•d funds 2023 R•¥trlct•d lund• 2023 Totsl 2023 Fund balanc•s at 31 D•e•mb•v 2023 •re r•pmented ty: Tangible asset5 CuNènt assels1ll1abilil￿6I Long lerm liabilitiès 31,IJ04 358,954 31,004 5.281.877 5.640.831 (2.383.283) 12,383,283) 389.958 2.898.594 3,288,552 Events aft•rth• rnportlng date The ¢hanly was nolffied ol an addthnal kgacy durirg Ihè prw ye81. The timing and amount of the legacy in¢orne is Un￿rtain a5 at the balar￿ sheet date and the￿fore no income relating to this legacy has been recognised in Ihese accounts. 32- DorJJsign EnV&￿e ID. 67DOF45D-315>4EW02>1CfjDD72875FO THE CHILDREN'S CANCER AND LEUKAEMIA GROUP OPERATING AS CCLG: THE CHILDREN AND YOUNG PEOPLE'S CANCER ASSOCIATION NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 24 op•rI￿n9 ￿al• ¢oMmits￿nts At the reporting end dale the charrty had outstanding commrfmgnts for firtUTe minimum lease payments under n0n-cancella￿e operating leases. whK* fall due as follows". 2024 2023 thin one year Behveen two and years 39,096 137,310 18,397 176.406 18,397 Amounts rectynised in th8 SOFA 88 an •xpense du￿n9 the pernd in resped of operaling18a8e orrawemenls 8r¢ £37,471 {2023- £36.5301. 25 Relatsd party tran••¢tlon• There have been no other relat•d party transactlons in the rèporting penod Ihal requir8 disdosure In Ihe financial $lalÈmenls. Ol￿r Ihan those noted in note 12 to the finanual stalgmenls. 26 C••h g•n•ratsd from op•rntlon• 2024 2023 (Defiutysurpus for th8 yoar {493,3521 827,655 Adju51menls for.. Inve51menl incomg recogn+￿￿ in 81alemenl ol finan(¥al actNiti•s Depreclalion and impairmMt of tangiblg fixed ossets 169.9311 9,228 156,17T) 14,074 Movements in working ¢aprtal.. Decreasellincrease) in slock$ Dè¢reasellincrea5el in deblors IOecreasollincr¢ase in ¢reditoTS Increase in d818rred Inc¥)me 9,042 1,986,481 12.143,549} 12,682 {2.0321 1451.2711 875,006 19,459 C••h lab•ort)od byyg•n•ratsd from op•r•JM• {689,399) 1,026,714 An•tysl$ of chang•s Sn n•tlunds During the year the chaiity had no l)offtMings or obligations undef finance leases. The thanges in nel funds of the charity the￿fore $¢lety comprise ofcash and cash aquival¢nls.